Brief Treatment for Trauma Nightmares in Trauma-exposed Adults With Bipolar Disorder

ConditionsNightmares Post-traumatic Stress Disorder

Trial statusRecruiting

Trial phaseNot applicable

Trial typeInterventional

Biological sexAll

Age18+

SponsorUniversity of Tulsa

About this trial

Exposure, relaxation, and rescripting therapy (ERRT) is a promising psychological intervention developed to target trauma-related nightmares and sleep disturbances. Though further evidence is needed, ERRT has shown strong support in reducing the number and intensity of nightmares, as well as improving overall sleep quality in both civilian and veteran samples. This study will assess the efficacy in individuals diagnosed with bipolar disorder.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Nightmares at least once per week for the past month

Formal diagnosis of Bipolar disorder (I or II)

Exposure to traumatic event (1+ months ago)

Stable on bipolar medication for at least 2 months

Disqualifiers

A traumatic event within the last month

Intellectual disability

Current or recent mania/hypomania within the last 3 months

Suicide attempt or hospitalization within the last 3 months

Trial design

Design model

Single group

Treatments tested in this trial

ERRT-Bipolar Disorder
Behavioral
The nightmare treatment, called Exposure, Relaxation, and Rescripting Therapy for Bipolar disorder, is a weekly 5-session treatment aimed at reducing chronic trauma nightmares and sleep disturbances in adults diagnosed with bipolar disorder.

Treatment groups

20 Participants

are divided into 1 treatment group

Group A: Nightmare TreatmentExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

Change in Past Week Nightmare Frequency

This fill-in-the-blank variable assesses the number of nightmares experienced in the past week (range = 0 - X nightmares) at each assessment (baseline, one week following treatment, and three months following treatment). Higher values indicate more nightmares (worse outcome).

Time frame

Pre, One week, Three Months

Secondary outcomes

Change in Clinician Administered PTSD Scale Symptoms

This semi-structured clinical interview assesses severity of each of 30 items

Time frame

Pre, One week, Three Months

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

University of Tulsa

Lead sponsor

Source ClinicalTrials.gov

Apply now